Huacui Chen
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- Cancer Cells and Metastasis
- Cancer Immunotherapy and Biomarkers
Papers in
-
- RNA modifications and cancer 4
- Epigenetics and DNA Methylation 3
- Cancer-related gene regulation 3
- RNA Research and Splicing 3
- Ubiquitin and proteasome pathways 2
- Oncology 4
- Lung Cancer Research Studies 1
- Co-authors
- Wanglin Li (9 shared papers)Zhuanpeng Chen (9 shared papers)Jie Cao (9 shared papers)Jianchang Wei (4 shared papers)Ping Yang (9 shared papers)He Hu (5 shared papers)Wei Fang (3 shared papers)Qiang Wang (1 shared paper)
- Journals
- Annals of Palliative Medicine (1 paper)Oncogene (1 paper)Oncotarget (1 paper)International Journal of Oncology (1 paper)The FASEB Journal (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Huacui Chen
13 papers receiving 413 citations
Peers
Comparison fields: 5 of 52
- Cancer Research 175
- Oncology 107
- Molecular Biology 231
- Immunology 54
- Biotechnology 11
Countries citing papers authored by Huacui Chen
This map shows the geographic impact of Huacui Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huacui Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huacui Chen more than expected).
Fields of papers citing papers by Huacui Chen
This network shows the impact of papers produced by Huacui Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huacui Chen. The network helps show where Huacui Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Huacui Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 147 | |
| 2 | 2018 | 93 | |
| 3 | 2016 | 35 | |
| 4 | 2018 | 30 | |
| 5 | 2017 | 28 | |
| 6 | 2018 | 21 | |
| 7 | 2017 | 16 | |
| 8 | 2022 | 14 | |
| 9 | 2017 | 12 | |
| 10 | 2018 | 11 | |
| 11 | 2021 | 4 | |
| 12 | [Effect of interleukin 17 on invasion of human colon cancer cells]. | 2016 | 2 |
| 13 | 2021 | 1 |
About Huacui Chen
Huacui Chen is a scholar working on Molecular Biology, Oncology, Cancer Research, Pharmacology and Plant Science, having authored 13 papers that have together received 414 indexed citations. Recurring topics across this work include RNA modifications and cancer (4 papers), Epigenetics and DNA Methylation (3 papers), Cancer-related gene regulation (3 papers), RNA Research and Splicing (3 papers), Ubiquitin and proteasome pathways (2 papers), Natural Compound Pharmacology Studies (2 papers), Cancer-related molecular mechanisms research (2 papers) and Lung Cancer Research Studies (1 paper). The work is most often cited by research in Cancer Research (175 citations), Oncology (107 citations), Molecular Biology (231 citations), Immunology (54 citations) and Biotechnology (11 citations). Huacui Chen has collaborated with scholars based in China and United States. Frequent co-authors include Wanglin Li, Zhuanpeng Chen, Jie Cao, Jianchang Wei, Ping Yang, He Hu, Wei Fang, Qiang Wang, Tong Zhang and Ping Yang. Their work appears in journals such as Annals of Palliative Medicine, Oncogene, Oncotarget, International Journal of Oncology and The FASEB Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.